Butterfly Network, Inc.
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BUTTERFLY NETWORK, INC. | ||
| Date: February 27, 2026 | By: | /s/ John Doherty |
|---|---|---|
| John Doherty | ||
| Executive Vice President, Chief Financial Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signatures | Title | Date | |||
|---|---|---|---|---|---|
| By: | /s/ Joseph DeVivo | President, Chief Executive Officer, and Chairman of the Board (Principal Executive Officer) | February 27, 2026 | ||
| Joseph DeVivo | |||||
| By: | /s/ John Doherty | Executive Vice President, Chief Financial Officer (Principal Financial Officer) | February 27, 2026 | ||
| John Doherty | |||||
| By: | /s/ Megan Carlson, CPA | Chief Accounting Officer and Senior Vice President, Finance (Principal Accounting Officer) | February 27, 2026 | ||
| Megan Carlson, CPA | |||||
| By: | /s/ Dawn Carfora | Director | February 27, 2026 | ||
| Dawn Carfora | |||||
| By: | /s/ Elazer Edelman, M.D., Ph.D. | Director | February 27, 2026 | ||
| Elazer Edelman, M.D., Ph.D. | |||||
| By: | /s/ S. Louise Phanstiel | Director | February 27, 2026 | ||
| S. Louise Phanstiel | |||||
| By: | /s/ Larry Robbins | Director | February 27, 2026 | ||
| Larry Robbins | |||||
| By: | /s/ Jonathan M. Rothberg, Ph.D. | Director | February 27, 2026 | ||
| Jonathan M. Rothberg, Ph.D. | |||||
| By: | /s/ Erica Schwartz, M.D., J.D., M.P.H. | Director | February 27, 2026 | ||
| Erica Schwartz, M.D., J.D., M.P.H. | |||||
INDEX TO FINANCIAL STATEMENTS
| Reports of Independent Registered Public Accounting Firm (PCAOB ID No: 34) | F-2 |
|---|---|
| Consolidated Balance Sheets | F-5 |
| Consolidated Statements of Operations and Comprehensive Loss | F-6 |
| Consolidated Statements of Changes in Stockholders’ Equity | F-7 |
| Consolidated Statements of Cash Flows | F-8 |
| Notes to the Consolidated Financial Statements | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.